biopharmaceuticals

November 22, 2024

Opinion

SKVARLA: North Carolina Medicare enrollees and innovation will be hurt by new drug pricing policy

February 12, 2020 John Skvarla

A proposed revision in drug pricing policy could negatively impact one of North Carolina’s most important industries as well as patients — especially the nearly 2 million North Carolina seniors and people with serious medical issues who […]

Opinion

LAWS: New Drug Pricing Model Hurts Medical Innovation

May 21, 2019 Michelle Laws

Through my experience working in the policy arena at the state d federal level, including during my time at NAMI-NC and in Washington, I have seen many different policy proposals come across my desk. Many of the […]